RecallDepth
Class II Terminated

Metformin Hydrochloride Extended-Release Tablets, USP 750 mg, a) 100 (NDC 62037-577-01) and b) 1000 (NDC 62037-577-10), Rx Only, Manufactured by: Watson Pharma Private Limited, Verna, Salcette Goa, Distributed by: Actavis Pharma, Inc., Parsippany, NJ

Company
Teva Pharmaceuticals Usa
Recall Initiated
June 2, 2020
Posted
July 1, 2020
Recall Number
D-1332-2020
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
a) 15,329 bottles and b) 137 bottles
Firm Location
Parsippany, NJ, United States

Reason for Recall

CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level

Distribution

Product was distributed throughout the United States, including Puerto Rico.

Lot / Code Info

a) 1333338M, exp. date 08/2020, 1333339A, exp. date 08/2020; b) 1354471A, exp. date 02/2021

More recalls by Teva Pharmaceuticals Usa

View all recalls by this company →

Other recent Class II Drug recalls